Intelligence Β· Patent portfolio
ENANTA PHARMACEUTICALS Patents
Full USPTO pharma patent portfolio for ENANTA PHARMACEUTICALS β grant dates, expiration, and drug cross-links.
- Patents
- 218
- Expiring β€24m
- 9
Quick answer
ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months β use filters for patent-cliff planning.
-
US 12384753
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
granted -
US 12358921
Antiviral heterocyclic compounds
granted -
US 12297209
Benzodiazepine derivatives as RSV inhibitors
granted -
US 12281140
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 12268694
Combination pharmaceutical agents as RSV inhibitors
granted -
US 12264159
Functionalized heterocycles as antiviral agents
granted -
US 12162857
Antiviral compounds
granted -
US 12145941
Heterocyclic antiviral agents
granted -
US 12054493
Hepatitis B antiviral agents
granted -
US 12018017
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 12011425
Hepatitis B antiviral agents
granted -
US 11993600
Saturated spirocyclics as antiviral agents
granted -
US 11970502
Macrocyclic antiviral agents
granted -
US 11958879
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11952389
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11945824
Heterocyclic compounds as anti-viral agents
granted -
US 11945830
Antiviral heterocyclic compounds
granted -
US 11919910
Spiropyrrolidine derived antiviral agents
granted -
US 11912714
Spiropyrrolidine derived antiviral agents
granted -
US 11912695
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11891393
Functionalized heterocycles as antiviral agents
granted -
US 11834436
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 11760755
Hepatitis B antiviral agents
granted -
US 11738019
Substituted heterocycles as antiviral agents
granted -
US 11718641
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11596611
Hepatitis B antiviral agents
granted -
US 11572367
Antiviral heterocyclic compounds
granted -
US 11560368
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 11534439
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
granted -
US 11472808
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
granted -
US 11420976
Heterocyclic compounds as anti-viral agents
granted -
US 11390631
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11377450
Functionalized heterocycles as antiviral agents
granted -
US 11358953
Functionalized peptides as antiviral agents
granted -
US 11352363
Spiropyrrolidine derived antiviral agents
granted -
US 11339170
Spiropyrrolidine derived antiviral agents
granted -
US 11325916
Spiropyrrolidine derived antiviral agents
granted -
US 11254664
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11236111
Hepatitis B antiviral agents
granted -
US 11198693
Functionalized heterocycles as antiviral agents
granted -
US 11179400
Heterocyclic compounds as RSV inhibitors
granted -
US 11091501
Heterocyclic compounds as RSV inhibitors
granted -
US 11058678
Substituted heterocycles as antiviral agents
granted -
US 11040998
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11034684
Isoxazole analogs as FXR agonists and methods of use thereof
granted -
US 11008304
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 10988458
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 10975094
Heterocyclic compounds as RSV inhibitors
granted
Frequently asked questions
How many patents does ENANTA PHARMACEUTICALS have?
218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ENANTA PHARMACEUTICALS patents expire?
9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory